86 related articles for article (PubMed ID: 9182140)
1. [Frequency of HPV infection and the level of ascorbic acid in serum of women with cervix dysplasia].
Kwaśniewska A; Tukendorf A; Semczuk M
Med Dosw Mikrobiol; 1996; 48(3-4):183-8. PubMed ID: 9182140
[TBL] [Abstract][Full Text] [Related]
2. [Frequency of HPV infection and level of glutathione in serum of women with cervix dysplasia].
Kwaśniewska A; Tukendorf A; Semczuk M
Med Dosw Mikrobiol; 1995; 47(3-4):213-8. PubMed ID: 8833934
[TBL] [Abstract][Full Text] [Related]
3. Plasma ascorbic acid and beta-carotene levels in women evaluated for HPV infection, smoking, and cervix dysplasia.
Basu J; Palan PR; Vermund SH; Goldberg GL; Burk RD; Romney SL
Cancer Detect Prev; 1991; 15(3):165-70. PubMed ID: 1647869
[TBL] [Abstract][Full Text] [Related]
4. The association of plasma micronutrients with the risk of cervical dysplasia in Hawaii.
Goodman MT; Kiviat N; McDuffie K; Hankin JH; Hernandez B; Wilkens LR; Franke A; Kuypers J; Kolonel LN; Nakamura J; Ing G; Branch B; Bertram CC; Kamemoto L; Sharma S; Killeen J
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):537-44. PubMed ID: 9641499
[TBL] [Abstract][Full Text] [Related]
5. [Use of the Digene Hybrid Capture System for identification of the human papillomavirus (HPV-Human Papillomavirus) in women with cervical dysplasia].
Kwaśniewska A; Semczuk M; Sikorski M; Kraczkowski J
Przegl Lek; 1997; 54(12):848-50. PubMed ID: 9591452
[TBL] [Abstract][Full Text] [Related]
6. A population-based study of squamous cell vaginal cancer: HPV and cofactors.
Daling JR; Madeleine MM; Schwartz SM; Shera KA; Carter JJ; McKnight B; Porter PL; Galloway DA; McDougall JK; Tamimi H
Gynecol Oncol; 2002 Feb; 84(2):263-70. PubMed ID: 11812085
[TBL] [Abstract][Full Text] [Related]
7. High sensitivity of PCR in situ hybridization for the detection of human papillomavirus infection in uterine cervical neoplasias.
Xiao Y; Sato S; Oguchi T; Kudo K; Yokoyama Y; Saito Y
Gynecol Oncol; 2001 Aug; 82(2):350-4. PubMed ID: 11531292
[TBL] [Abstract][Full Text] [Related]
8. Low incidence of HPV DNA in sera of pretreatment cervical cancer patients.
Liu VW; Tsang P; Yip A; Ng TY; Wong LC; Ngan HY
Gynecol Oncol; 2001 Aug; 82(2):269-72. PubMed ID: 11531278
[TBL] [Abstract][Full Text] [Related]
9. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic value of cytomorphological traits in low and high risk type HPV infections.
Korobowicz E; Kwaśniewska A; Georgiades I
Pol J Pathol; 1997; 48(2):107-12. PubMed ID: 9278107
[TBL] [Abstract][Full Text] [Related]
11. Frequent detection of human papilloma viruses in cervical dysplasia by PCR single-strand DNA-conformational polymorphism analysis.
Nakagawa H; Sugano K; Fujii T; Kubushiro K; Tsukazaki K; Nozawa S
Anticancer Res; 2002; 22(3):1655-60. PubMed ID: 12168850
[TBL] [Abstract][Full Text] [Related]
12. [Study of the association between human papillomavirus infection and cervical cancer in Xianguan county, Shanxi province].
Zhao F; Li N; Ma J
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Oct; 22(5):375-8. PubMed ID: 11769697
[TBL] [Abstract][Full Text] [Related]
13. Frequency of HPV infection and GSH levels in plasma of women with cervical dysplasia.
Kwaśniewska A; Tukendorf A; Semczuk M
Eur J Gynaecol Oncol; 1997; 18(3):196-9. PubMed ID: 9174835
[TBL] [Abstract][Full Text] [Related]
14. [The relationship with human papilloma virus DNA in cervical adenocarcinoma].
Ogura K; Ishi K; Suzuki F; Suto H; Kina K; Koyatsu J; Nojima M; Yoshida K; Suda K
Rinsho Byori; 2004 Feb; 52(2):115-9. PubMed ID: 15027314
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant nutrients: associations with persistent human papillomavirus infection.
Giuliano AR; Papenfuss M; Nour M; Canfield LM; Schneider A; Hatch K
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):917-23. PubMed ID: 9367065
[TBL] [Abstract][Full Text] [Related]
16. [Detection of human papillomavirus DNA in cervical squamous cell carcinoma in Xinjiang Uygur women].
Suzuk L; Noffsinger AE; Aili M
Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):405-8. PubMed ID: 9639725
[TBL] [Abstract][Full Text] [Related]
17. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract.
Vinokurova S; Wentzensen N; Einenkel J; Klaes R; Ziegert C; Melsheimer P; Sartor H; Horn LC; Höckel M; von Knebel Doeberitz M
J Natl Cancer Inst; 2005 Dec; 97(24):1816-21. PubMed ID: 16368943
[TBL] [Abstract][Full Text] [Related]
18. Content of beta-carotene in blood serum of human papillomavirus infected women with cervical dysplasias.
Kwaśniewska A; Tukendorf A; Semczuk M
Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):309-13. PubMed ID: 9017145
[TBL] [Abstract][Full Text] [Related]
19. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
20. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
